Here is the link to this study on ClinicalTrials.gov:
A Study of IMU-131 (HER-Vaxx) in Combination With Chemotherapy or Pembrolizumab in Patients With Metastatic HER2/Neu Over-Expressing Gastric Cancer (nextHERIZON / KEYNOTE D87) - Full Text View - ClinicalTrials.gov
Ann: Imugene HER-Vaxx Clinical Trial Collaboration with Merck, page-170
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
-0.001(1.04%) |
Mkt cap ! $353.3M | |||
| Open | High | Low | Value | Volume |
| 4.8¢ | 4.8¢ | 4.7¢ | $311.9K | 6.523M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 31 | 4305967 | 4.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.8¢ | 879911 | 9 |
View Market Depth
| Last trade - 14.20pm 12/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |